Thejasvi Thiruvoipati is a Cardiology physician. OpenAlex indexes 14 publications with 708 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
280 Exempla Cir
Lafayette, CO 800263370
Telephone
303-724-2105Provider last certified this registry record 23 May 2021.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20256 payments
- Edwards Lifesciences CorporationProgram year20253 payments
- Abbott LaboratoriesProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.9%Beta blocker26.1%Metoprolol Succinate35%Metoprolol Tartrate32%Carvedilol21%Bisoprolol Fumarate12%Part D<11 patientsStatin15.7%Atorvastatin Calcium70%Rosuvastatin Calcium30%Part D≥31 patients+ 9 more classes in this area
Blood & clotting
12.4%P2Y12 inhibitor9.2%Clopidogrel100%Part D≥28 patientsDirect thrombin inhibitors3.2%Pradaxa100%Part D≥13 patientsMetabolism & gastrointestinal
1.7%SGLT2 inhibitor1.7%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TIMING MATTERS – HYDRATION STRATEGIES TO REDUCE CONTRAST INDUCED NEPHROPATHY AFTER PERIPHERAL VASCULAR INTERVENTIONS: OBSERVATIONS FROM THE BLUE CROSS BLUE SHIELD CARDIOVASCULAR CONSORTIUM (BMC2)
Journal of the American College of Cardiology
2017 - IS PREOPERATIVE STRESS TESTING ASSOCIATED WITH 30-DAY POSTOPERATIVE MORTALITY IN PATIENTS PRIOR PCI UNDERGOING NONCARDIAC SURGERY: INSIGHTS FROM THE VETERANS AFFAIRS HEALTH CARE SYSTEM
Journal of the American College of Cardiology
2016 - Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes
World Journal of Diabetes
2015 - Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis
Journal of Endovascular Therapy
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”